Search | SciELO

ABSTRACT The limited temporal completeness and taxonomic accuracy of species lists, made available in a traditional manner in scientific publications, has always represented a problem. These lists are invariably limited to a few taxonomic groups and do not represent up-to-date knowledge of all species and classifications. In this context, the Brazilian megadiverse fauna is no exception, and the Catálogo Taxonômico da Fauna do Brasil (CTFB) (http://fauna.jbrj.gov.br/), made public in 2015, represents a database on biodiversity anchored on a list of valid and expertly recognized scientific names of animals in Brazil. The CTFB is updated in near real time by a team of more than 800 specialists. By January 1, 2024, the CTFB compiled 133,691 nominal species, with 125,138 that were considered valid. Most of the valid species were arthropods (82.3%, with more than 102,000 species) and chordates (7.69%, with over 11,000 species). These taxa were followed by a cluster composed of Mollusca (3,567 species), Platyhelminthes (2,292 species), Annelida (1,833 species), and Nematoda (1,447 species). All remaining groups had less than 1,000 species reported in Brazil, with Cnidaria (831 species), Porifera (628 species), Rotifera (606 species), and Bryozoa (520 species) representing those with more than 500 species. Analysis of the CTFB database can facilitate and direct efforts towards the discovery of new species in Brazil, but it is also fundamental in providing the best available list of valid nominal species to users, including those in science, health, conservation efforts, and any initiative involving animals. The importance of the CTFB is evidenced by the elevated number of citations in the scientific literature in diverse areas of biology, law, anthropology, education, forensic science, and veterinary science, among others. publications problem uptodate up date classifications context exception (CTFB http//fauna.jbrj.gov.br/, httpfaunajbrjgovbr http //fauna.jbrj.gov.br/ , jbrj gov br (http://fauna.jbrj.gov.br/) 2015 Brazil 80 specialists 1 2024 133691 133 691 133,69 125138 125 138 125,13 82.3%, 823 82 3 (82.3% 102000 102 000 102,00 7.69%, 769 7 69 (7.69% 11000 11 11,00 . 3,567 3567 567 (3,56 2,292 2292 2 292 (2,29 1,833 1833 833 (1,83 1,447 1447 447 (1,44 1000 1,00 831 (83 628 (62 606 (60 520 (52 50 users science health biology law anthropology education others http//fauna.jbrj.gov.br/ faunajbrjgovbr //fauna.jbrj.gov.br (http://fauna.jbrj.gov.br/ 201 8 202 13369 13 133,6 12513 12 125,1 82.3% (82.3 10200 10 00 102,0 7.69% 76 6 (7.69 1100 11,0 3,56 356 56 (3,5 2,29 229 29 (2,2 1,83 183 83 (1,8 1,44 144 44 (1,4 100 1,0 (8 62 (6 60 52 (5 5 http//fauna.jbrj.gov.br (http://fauna.jbrj.gov.br 20 1336 133, 1251 125, 82.3 (82. 1020 0 102, 7.69 (7.6 110 11, 3,5 35 (3, 2,2 22 (2, 1,8 18 (1, 1,4 14 4 ( 82. (82 7.6 (7. 3, (3 2, (2 (1 7. (7

ABSTRACT Purpose: Bacterial cellulose (BC) has shown high capacity for the treatment of wounds and burns, providing a moisty environment. Calcium alginate can be associated with BC to create gels that aid in wound debridement and contribute to appropriate wound healing. This study is aimed at characterizing and evaluating the use of bacterial cellulose/alginate gel in skin burns in rats. Methods: Cellulose and cellulose/alginate gels were compared regarding the capacity of liquid absorption, moisture, viscosity, and potential cytotoxicity. The 2nd degree burns were produced using an aluminum metal plate (2.0cm) at 120ºC for 20s on the back of rats. The animals were divided into non-treated, CMC(Carboxymethylcellulose), Cellulose(CMC with bacterial cellulose), and Cellulose/alginate(CMC with bacterial cellulose and alginate). The animals received topical treatment 3 times/week. Biochemical (MPO, NAG and oxidative stress), histomorphometry and immunohistochemical assays (IL-1β IL-10 and VEGF) were conducted on the 14th, 21st, 28th, and 35th days. Results: Cellulose/Alginate gel showed higher absorption capacity and viscosity compared to Cellulose gel, with no cytotoxic effects. Cellulose/alginate presented lower MPO values, a higher percentage of IL-10, with greater and balanced oxidative stress profile. Conclusions: The use of cellulose/alginate gel reduced neutrophils and macrophage activation and showed greater anti-inflammatory response, which can contribute to healing chronic wounds and burns. Purpose (BC environment cellulosealginate rats Methods moisture cytotoxicity nd 2.0cm 20cm cm 2 0cm (2.0cm ºC s nontreated, nontreated non treated, treated non-treated CMCCarboxymethylcellulose, CMCCarboxymethylcellulose CMC Carboxymethylcellulose , CMC(Carboxymethylcellulose) CelluloseCMC cellulose, cellulose) Cellulose/alginateCMC CellulosealginateCMC alginate. . alginate) timesweek times week times/week MPO, (MPO stress, stress) IL1β ILβ IL 1β β IL10 10 IL-1 VEGF 14th th 21st st 28th days Results CelluloseAlginate Alginate effects Cellulosealginate values IL10, 10, profile Conclusions antiinflammatory anti inflammatory response CMC(Carboxymethylcellulose alginateCMC IL1 1 IL-

RESUMO Objetivo Estimar a prevalência do esquema vacinal completo dos 12 aos 24 meses de vida e analisar os fatores associados ao esquema vacinal completo. Métodos Inquérito com amostragem por conglomerados realizado em Vitória, Espírito Santo, entre 16 de dezembro de 2020 e 4 de janeiro de 2021. Foram incluídas crianças nascidas em Vitória nos anos de 2017 e 2018. Estimamos as prevalências dos esquemas vacinais. Utilizou-se regressão de Poisson para verificar a associação com a cobertura vacinal. Resultados Incluímos 788 crianças. A cobertura vacinal foi de 57% [intervalo de confiança de 95% (IC95%) 50,98;62,98]. Utilizar serviço privado para imunização [razão de prevalência (RP) 0,67; IC95% 0,51;0,86] e mãe ter ≥ 4 filhos (RP 0,55; IC95% 0,32;0,94) apresentaram as menores prevalências de cobertura vacinal completa. Conclusão Encontramos baixa cobertura vacinal com diminuição nas doses de reforço. Utilizar serviço privado para imunização e o número de filhos foram associados à cobertura vacinal incompleta. 1 2 Santo 202 2021 201 2018 vacinais Utilizouse Utilizou se 78 57 intervalo 95 IC95 IC (IC95% 50,9862,98. 50986298 50,98 62,98 . 50 98 62 50,98;62,98] razão RP 0,67 067 0 67 0,510,86 051086 0,51 0,86 51 86 0,51;0,86 0,55 055 55 0,320,94 032094 0,32 0,94 32 94 0,32;0,94 completa reforço incompleta 20 7 5 9 IC9 (IC95 9862 50,9862,98 5098629 5098 50,9 6298 62,9 6 50,98;62,98 0,6 06 510 0,510,8 05108 051 0,5 086 0,8 8 0,51;0,8 05 320 0,320,9 03209 032 0,3 094 0,9 3 0,32;0,9 (IC9 986 50,9862,9 509862 509 50, 629 62, 50,98;62,9 0, 0,510, 0510 08 0,51;0, 0,320, 0320 03 09 0,32;0, (IC 50,9862, 50986 50,98;62, 0,510 0,51;0 0,320 0,32;0 50,9862 50,98;62 0,51; 0,32; 50,986 50,98;6 50,98;

ABSTRACT Objective To estimate prevalence of the full vaccination schedule for children 12 to 24 months old and to analyze associated factors. Methods Survey with cluster sampling carried out in Vitória, Espírito Santo, Brazil, between December 16, 2020, and January 4, 2021. Children born in Vitória in 2017 and 2018 were included. We estimated the prevalence of vaccination schedules. Poisson regression was used to verify association with full vaccination coverage. Results We included 788 children. Full vaccination coverage was found to be 57% taking a 95% confidence interval (95%CI 50.98;62.98). Prevalence of full vaccination coverage was lowest when private services were used for immunization (prevalence ratio [PR] 0.67; 95%CI 0.51;0.86) and when mothers had ≥ 4 children (PR 0.55; 95%CI 0.32;0.94). Conclusion We found low vaccination coverage and a drop in booster doses. Use of private services for immunization and number of children were associated with incomplete vaccination coverage. 1 2 factors Santo Brazil 16 2020 2021 201 schedules 78 57 95 95CI CI 50.9862.98. 50986298 50.98 62.98 . 50 98 62 50.98;62.98) PR [PR 0.67 067 0 67 0.510.86 051086 0.51 0.86 51 86 0.51;0.86 0.55 055 55 0.320.94. 032094 0.32 0.94 32 94 0.32;0.94) doses 202 20 7 5 9 9862 50.9862.98 5098629 5098 50.9 6298 62.9 6 50.98;62.98 0.6 06 510 0.510.8 05108 051 0.5 086 0.8 8 0.51;0.8 05 320 0.320.94 03209 032 0.3 094 0.9 3 0.32;0.94 986 50.9862.9 509862 509 50. 629 62. 50.98;62.9 0. 0.510. 0510 08 0.51;0. 0.320.9 0320 03 09 0.32;0.9 50.9862. 50986 50.98;62. 0.510 0.51;0 0.320. 0.32;0. 50.9862 50.98;62 0.51; 0.320 0.32;0 50.986 50.98;6 0.32; 50.98;

Index code	Element
ti	article title
au	author
kw	article keywords
subject	subject (title words, abstract and keywords)
ab	abstract
ta	journal short title (e.g. Cad. Saúde Pública)
journal_title	journal full title (e.g. Cadernos de Saúde Pública)
la	publication language code (e.g. pt - Portuguese, es - Spanish)
type	document type
pid	publication identifier
publication_year	publication year of publication
sponsor	sponsor
aff_country	country code of the author's affiliation
aff_institution	author affiliation institution
volume	article volume
issue	article issue
elocation	elocation
doi	DOI number
issn	journal ISSN
in	SciELO colection code (e.g. scl - Brasil, col - Colômbia)
use_license	article usage license code

No documents were found for your search